José J. Pérez

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

Bruno Paiva, María‐Belén Vídriales, Jorge Cerveró et al. · Blood · 2008 · 463 citations · Full text

Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Christopher T. Chan, Peter J. Blankestijn, Laura M. Dember et al. · Kidney International · 2019 · 404 citations · Full text

Hemodialysis, Renal Disease, Health Policy +13

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

Jesús F. San Miguel, María‐Belén Vídriales, C López-Berges et al. · Blood · 2001 · 331 citations · Full text

Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients

Bruno Paiva, María‐Belén Vídriales, José J. Pérez et al. · Haematologica · 2009 · 108 citations · Full text

Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma

Juan‐José Garcés, María‐Teresa Cedena, Noemí Puig et al. · Journal of Clinical Oncology · 2022 · 105 citations · Full text

Transplant-eligible Multiple Myeloma, Hematological Malignancy, Cell Therapy +15